Immunodeficiency	NN	_
disorders	NNS	_
(	-LRB-	_
representing	VBG	_
an	DT	_
underactive	JJ	_
immune	JJ	_
system	NN	_
)	-RRB-	_
have	VBP	_
been	VBN	_
reported	VBN	_
.	.	_

As	RB	_
early	RB	_
as	IN	_
1989	CD	_
,	,	_
a	DT	_
study	NN	_
was	VBD	_
published	VBN	_
in	IN	_
Australia	NNP	_
that	WDT	_
documented	VBD	_
a	DT	_
loss	NN	_
of	IN	_
immunological	JJ	_
integrity	NN	_
in	IN	_
one	CD	_
hundred	CD	_
CFS	NNP	_
sufferers	NNS	_
.	.	_

The	DT	_
authors	NNS	_
reported	VBD	_
finding	VBG	_
disordered	JJ	_
ratios	NNS	_
of	IN	_
T	NN	_
-	HYPH	_
cell	NN	_
subsets	NNS	_
and	CC	_
reduced	JJ	_
levels	NNS	_
of	IN	_
immunoglobulins	NNS	_
specifically	RB	_
IgG	NNP	_
1	CD	_
and	CC	_
IgG	NNP	_
3	CD	_
;	:	_
these	DT	_
findings	NNS	_
corresponded	VBD	_
with	IN	_
similar	JJ	_
findings	NNS	_
in	IN	_
the	DT	_
U.S.	NNP	_
among	IN	_
leading	VBG	_
researchers	NNS	_
.	.	_

Most	JJS	_
strikingly	RB	_
,	,	_
using	VBG	_
the	DT	_
French	JJ	_
Multitest	NNP	_
to	TO	_
measure	VB	_
the	DT	_
body	NN	_
's	POS	_
response	NN	_
to	IN	_
a	DT	_
variety	NN	_
of	IN	_
antigens	NNS	_
,	,	_
the	DT	_
Australian	JJ	_
group	NN	_
found	VBD	_
that	IN	_
33	CD	_
%	NN	_
of	IN	_
the	DT	_
subjects	NNS	_
were	VBD	_
hypoallergic	JJ	_
,	,	_
meaning	VBG	_
they	PRP	_
had	VBD	_
a	DT	_
reduced	VBN	_
immune	JJ	_
response	NN	_
,	,	_
while	IN	_
an	DT	_
additional	JJ	_
55	CD	_
%	NN	_
were	VBD	_
completely	RB	_
anergic	JJ	_
,	,	_
meaning	VBG	_
they	PRP	_
had	VBD	_
no	DT	_
immune	JJ	_
response	NN	_
at	IN	_
all	RB	_
.	.	_

Some	DT	CUE-1
theories	NNS	CUE-1
propose	VB	_
that	IN	_
an	DT	_
infection	NN	_
with	IN	_
one	CD	_
of	IN	_
the	DT	_
below	RB	_
-	HYPH	_
listed	VBN	_
disease	NN	_
agents	NNS	_
somehow	RB	_
leads	VBZ	_
to	IN	_
immune	VB	_
dysfunction	NN	_
and	CC	_
chronic	JJ	_
fatigue	NN	_
in	IN	_
cases	NNS	_
of	IN	_
CFS.	NNP	_

This	DT	_
is	VBZ	_
partly	RB	_
supported	VBN	_
by	IN	_
test	NN	_
results	NNS	_
indicating	VBG	_
lowered	VBN	_
or	CC	_
changed	VBN	_
immune	JJ	_
responses	NNS	_
in	IN	_
some	DT	_
patients	NNS	_
,	,	_
as	RB	_
well	RB	_
as	IN	_
elevated	JJ	_
levels	NNS	_
of	IN	_
infectious	JJ	_
agents	NNS	_
in	IN	_
some	DT	_
patients	NNS	_
'	POS	_
blood	NN	_
.	.	_

